Considerations for Pneumococcal Conjugate Vaccine (PCV) Product Choice

This document is includes information on WHO position on pneumococcal vaccines in infants in children; vaccine characteristics; safety; PCV performance; programmatic considerations; cost and financial considerations; availability and supply; prioritization among new vaccine introduction decisions.

Authors